Get startedLog in
    Picture of HLS Therapeutics logo

    HLS — HLS Therapeutics News Story

    0.000.00%
    ca flag iconLast trade - 00:00
    HealthcareBalancedSmall CapNeutral
    All News

    Brief: HLS Therapeutics Completes Negotiations With PCPS For Vascepa

    Picture of HLS Therapeutics logoHLS Therapeutics
    26/04/2022 11:34
    April 26 (Reuters) - HLS Therapeutics Inc  HLS.TO :
    * HLS THERAPEUTICS COMPLETES NEGOTIATIONS WITH PCPA FOR VASCEPA®
    * HLS THERAPEUTICS - ENTERS INTO LOI THAT PAVES WAY FOR PRODUCT LISTING
AGREEMENTS
FOR VASCEPA WITH ALL OF CANADA'S PROVINCES AND TERRITORIES
    * HLS THERAPEUTICS INC - UPDATES ITS PEAK-YEAR SALES ESTIMATE TO $250-$300
MILLION
IN REVENUE WITH ADJUSTED EBITDA MARGIN OF APPROXIMATELY 30%
    * HLS THERAPEUTICS INC - PEAK-YEAR ESTIMATES EXPECTED TO BE REACHED IN 2026
    * HLS THERAPEUTICS INC - ALL FINANCIAL FIGURES ARE IN CANADIAN DOLLARS

Source text for Eikon:  ID:nCNWSfMCma 
Further company coverage:  HLS.TO 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on HLS Therapeutics

    See all news